Gossamer Bio Statistics
Share Statistics
Gossamer Bio has 226.60M shares outstanding. The number of shares has increased by 0.45% in one year.
| Shares Outstanding | 226.60M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.17% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 174.03M |
| Failed to Deliver (FTD) Shares | 36 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 7.02M, so 3.1% of the outstanding shares have been sold short.
| Short Interest | 7.02M |
| Short % of Shares Out | 3.1% |
| Short % of Float | 4.03% |
| Short Ratio (days to cover) | 3.21 |
Valuation Ratios
The PE ratio is -0.77 and the forward PE ratio is -1.23.
| PE Ratio | -0.77 |
| Forward PE | -1.23 |
| PS Ratio | 0 |
| Forward PS | 3.6 |
| PB Ratio | 2.22 |
| P/FCF Ratio | -0.88 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Gossamer Bio Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.94, with a Debt / Equity ratio of 3.33.
| Current Ratio | 5.94 |
| Quick Ratio | 5.94 |
| Debt / Equity | 3.33 |
| Total Debt / Capitalization | 76.91 |
| Cash Flow / Debt | -0.76 |
| Interest Coverage | -13.6 |
Financial Efficiency
Return on equity (ROE) is -2.86% and return on capital (ROIC) is -66.76%.
| Return on Equity (ROE) | -2.86% |
| Return on Assets (ROA) | -0.58% |
| Return on Capital (ROIC) | -66.76% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.33M |
| Employee Count | 135 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 18.82% in the last 52 weeks. The beta is 1.96, so Gossamer Bio 's price volatility has been higher than the market average.
| Beta | 1.96 |
| 52-Week Price Change | 18.82% |
| 50-Day Moving Average | 0.82 |
| 200-Day Moving Average | 0.87 |
| Relative Strength Index (RSI) | 71.17 |
| Average Volume (20 Days) | 1.29M |
Income Statement
| Revenue | n/a |
| Gross Profit | -4.38M |
| Operating Income | -183.76M |
| Net Income | -179.82M |
| EBITDA | -172.15M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.18 |
Balance Sheet
The company has 32.11M in cash and 212.46M in debt, giving a net cash position of -180.35M.
| Cash & Cash Equivalents | 32.11M |
| Total Debt | 212.46M |
| Net Cash | -180.35M |
| Retained Earnings | -1.21B |
| Total Assets | 350.88M |
| Working Capital | 293.18M |
Cash Flow
In the last 12 months, operating cash flow was -159.16M and capital expenditures 0, giving a free cash flow of -159.16M.
| Operating Cash Flow | -159.16M |
| Capital Expenditures | 0 |
| Free Cash Flow | -159.16M |
| FCF Per Share | -1.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GOSS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -116.83% |
| FCF Yield | -69.2% |
Analyst Forecast
The average price target for GOSS is $9, which is 791.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $9 |
| Price Target Difference | 791.1% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Scores
| Altman Z-Score | -3.79 |
| Piotroski F-Score | 4 |